BIOXNasdaqAgricultural ChemicalsFiscal year ends June 30
Bioceres Crop Solutions Corp.
Financials through Q2 FY2026, quarter ended Dec 31, 2025Last filing: 20-F on Nov 10, 2025
$0.26−0.02 (-7.44%)
Close on Oct 19, 2026
- Market cap
- $16.19M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.4449 (−84.99%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Bioceres Crop Solutions Corp. saw revenue fall 28.4% to $286.54M over the twelve months to Dec 31, 2025. Operating income fell 94.5% to $2.21M, moving the operating margin from 10.1% to 0.8%. Free cash flow was $78.37M.
Revenue
$286.54M
-28.4% vs. a year earlier
Operating income
$2.21M
-94.5% vs. a year earlier
Free cash flow
$78.37M
TTM Q2 2026
EPS, diluted
-$3.76
-12759.6% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Dec 31, 2025
Valuation
- Market cap
- $16.19M
- P/E ratio
- –
- Price to sales
- 0.06
- Price to book
- 0.21
- Dividend yield
- –
- Free cash flow yield
- 483.95%
Fundamentals
- Revenue
- $286.54M
- Net income
- -$55.42M
- EPS, diluted
- -$3.76
- Free cash flow
- $78.37M
- Book value per share
- $1.20
- Diluted shares
- 63M
Eight years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
$286.54M-28.4% YoY
Gross profit
$112.01M-33.8% YoY
Operating income
$2.21M-94.5% YoY
Net income
–
EPS, diluted
-$3.76-12759.6% YoY
Free cash flow
$78.37M
Reported periodTrailing twelve months